[co-author: Michael Lisitano]*
The Connecticut Department of Consumer Protection Drug Control Division (DCP) has issued guidance for health care providers regarding refills and reissuances of controlled substance prescriptions for patients without an in-person visit due to the COVID-19 pandemic. DCP explains that “practitioners may issue prescription refills for controlled substances using their professional discretion for a patient under their care without seeing the patient in-person within certain parameters.” The parameters are as follows:
DCP has made a number of resources available to registered practitioners in Connecticut to support efforts to ensure access to care and medication in a safe manner during the COVID-19 emergency. Practitioners would be well-advised to review the DCP guidance closely, and to contact DCP with questions. Practitioners should also keep in mind that as of March 30, current restrictions under Connecticut law on the use of telehealth to issue new controlled substance prescriptions for certain conditions remain in effect.
*Legal Intern at Robinson+Cole. Michael is not yet admitted to practice law.